Main menu
Common skin conditions
NEWS
Join DermNet PRO
Read more
Quick links
Blood vessel problems Connective tissue diseases
Last Reviewed: December, 2025
Author: Meghan Kanou, Université de Montréal, Québec, Canada (2025)
Peer reviewed by: Dr Ishana Dixit, Dermatology Research Fellow, Westmead Hospital, NSW, Australia (2025)
Reviewing dermatologist: Dr Ian Coulson
Edited by the DermNet content department.
Introduction
Demographics
Causes
Clinical features
Variation in skin types
Complications
Diagnosis
Differential diagnoses
Treatment
Prevention
Outcome
CLAPO syndrome is a rare genetic vascular disorder characterised by capillary malformation of the lower lip, lymphatic malformation of the face and neck, asymmetry, and partial/generalised overgrowth.
This condition is also known as Lopez-Gutierrez syndrome.
CLAPO syndrome arises from a sporadic somatic mutation and is not inherited. It has an estimated prevalence of less than 1 in 1,000,000, with no known gender or racial predilection.
CLAPO syndrome is caused by somatic gain-of-function mutations of the PIK3CA (phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha) gene, which is responsible for regulating cell division and growth.
CLAPO syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS), alongside conditions such as MCAP and CLOVES syndrome.
For people with darker skin tones, capillary malformations may be less visible but can be distinguished by their maroon colour.
The complications of CLAPO syndrome are usually related to the lymphatic malformations and include:
CLAPO syndrome is primarily a clinical diagnosis based on the presence of key features, such as capillary malformation of the lower lip and lymphatic malformations.
Diagnosis is confirmed by genetic testing of affected tissue, revealing a PIK3CA gene mutation.
Routine follow-ups in children with capillary malformation to prevent potential complications of lymphatic malformations.
There is no known way to prevent CLAPO syndrome.
Early recognition and ongoing monitoring of CLAPO syndrome are essential to optimise treatment success and minimise the occurrence of potential complications. The capillary malformation can remain stable or even improve without treatment.